FFA
TMO icon

First Foundation Advisors’s Thermo Fisher Scientific TMO Stock Holding History

First Foundation Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$602K Buy
1,224
+92
+8% +$49.9K 0.02% 217
2025
Q4 		$656K Buy
1,132
+158
+16% +$89.3K 0.02% 205
2025
Q3 		$472K Sell
974
-1,131
-54% -$526K 0.02% 237
2025
Q2 		$853K Buy
2,105
+648
+44% +$271K 0.03% 200
2025
Q1 		$725K Buy
1,457
+914
+168% +$495K 0.03% 194
2024
Q4 		$282K Buy
543
+3
+0.6% +$1.65K 0.01% 294
2024
Q3 		$334K Sell
540
-193
-26% -$114K 0.01% 270
2024
Q2 		$405K Sell
733
-85
-10% -$48.7K 0.02% 246
2024
Q1 		$475K Sell
818
-62
-7% -$34.8K 0.02% 232
2023
Q4 		$467K Sell
880
-1,225
-58% -$593K 0.02% 238
2023
Q3 		$1.07M Buy
2,105
+128
+6% +$68.2K 0.05% 174
2023
Q2 		$1.03M Buy
1,977
+126
+7% +$68K 0.04% 174
2023
Q1 		$1.07M Buy
1,851
+196
+12% +$110K 0.05% 173
2022
Q4 		$911K Buy
1,655
+33
+2% +$17.5K 0.04% 189
2022
Q3 		$823K Sell
1,622
-59
-4% -$33K 0.04% 185
2022
Q2 		$913K Buy
1,681
+107
+7% +$58.9K 0.04% 182
2022
Q1 		$930K Buy
1,574
+353
+29% +$203K 0.03% 194
2021
Q4 		$815K Buy
1,221
+56
+5% +$35K 0.03% 219
2021
Q3 		$666K Buy
1,165
+286
+33% +$157K 0.02% 240
2021
Q2 		$443K Sell
879
-249
-22% -$117K 0.02% 301
2021
Q1 		$515K Sell
1,128
-875
-44% -$418K 0.02% 261
2020
Q4 		$933K Buy
2,003
+84
+4% +$39.4K 0.04% 196
2020
Q3 		$847K Sell
1,919
-120
-6% -$49.6K 0.04% 192
2020
Q2 		$739K Sell
2,039
-565
-22% -$189K 0.04% 196
2020
Q1 		$738K Buy
2,604
+1,606
+161% +$506K 0.05% 189
2019
Q4 		$324K Buy
998
+79
+9% +$24K 0.02% 285
2019
Q3 		$268K Sell
919
-3
-0.3% -$859 0.01% 302
2019
Q2 		$271K Sell
922
-59
-6% -$16.3K 0.02% 290
2019
Q1 		$269K Buy
+981
New +$244K 0.02% 284

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

First Foundation Advisors's TMO Position: Q1 2026 in Review

First Foundation Advisors increased its Thermo Fisher Scientific (TMO) stake by 8.1% in Q1 2026, buying an estimated $49.9K and bringing the position to 1,224 shares worth $602K. The position accounts for 0.02% of the portfolio, ranked #217.

First Foundation Advisors first reported a position in TMO in Q1 2019 and has held it in 29 quarters since. The position peaked at $1.07M in Q1 2023. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • First Foundation Advisors held 1,224 shares of Thermo Fisher Scientific worth $602K as of Q1 2026.
  • First Foundation Advisors bought 92 Thermo Fisher Scientific shares in Q1 2026, an estimated $49.9K.
  • Thermo Fisher Scientific made up 0.02% of First Foundation Advisors's portfolio in Q1 2026, its #217 holding.
  • First Foundation Advisors first reported a position in Thermo Fisher Scientific in Q1 2019 and has held it in 29 quarters since.
  • First Foundation Advisors's Thermo Fisher Scientific position peaked at $1.07M in Q1 2023.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on First Foundation Advisors's 13F filing for Q1 2026, filed 4 May 2026.